Keyphrases
Adjusted Odds Ratio
9%
AIDS/HIV
23%
Antithymocyte Globulin
23%
Bloodstream Infection
46%
Breakthrough Invasive Fungal Infections
13%
Chronic Diarrhea
19%
Coronavirus
23%
Deceased Donor
23%
Diarrhea
23%
Drain Site
23%
Glucocorticoid Therapy
23%
Graft Outcome
23%
Haematopoietic Stem Cell Transplant Recipients
46%
Hazard Ratio
9%
Hematological Malignancies
93%
Hematopoietic Cell Transplant
39%
Illness
9%
Induction Immunosuppression
23%
Induction Type
18%
Influenza
15%
Intensive Care Unit Admission
16%
Interleukin-2 Receptor Antagonist
23%
Inverse Probability of Treatment Weighting
23%
Isavuconazole
23%
Kidney Graft
23%
Kidney Transplant Recipients
23%
Meropenem
8%
Multicenter Cohort
23%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
23%
Non-susceptible
31%
Nucleic Acid Testing
23%
Pneumocystis Jirovecii
23%
Pregenomic RNA (pgRNA)
11%
Pseudomonas Aeruginosa (P. aeruginosa)
23%
Pseudomonas Aeruginosa Bacteraemia
23%
Pseudomonas Aeruginosa Colonization
23%
Respiratory Infection
23%
Severe Acute Respiratory Syndrome
23%
Solid Organ Transplant Recipients
46%
Stem Cell Transplant Recipients
23%
Symptom Onset
11%
Transplant Center
7%
United States
26%
Viable Virus
17%
Viral Culture
11%
Viral RNA Shedding
11%
Viral Shedding
23%
Virus
23%
Wastewater
23%
Weight Analysis
23%
Medicine and Dentistry
Antiviral Therapy
7%
Bloodstream Infection
46%
Carbapenem
23%
Chronic Diarrhea
19%
Cohort Effect
7%
Coronavirinae
23%
Diarrhea
23%
Disease
9%
Disease Severity
5%
Glucocorticoid
23%
Graft Survival
6%
Hematologic Malignancy
69%
Hematopoietic Cell
46%
HIV Test
6%
Hospital Infection
5%
Human Immunodeficiency Virus
23%
Infection
9%
Infection Control
13%
Infection Prevention
5%
Intensive Care Unit
16%
Kidney Graft
23%
Meropenem
8%
Molecular Diagnosis
7%
Mortality Rate
6%
Nucleic Acid
23%
Odds Ratio
9%
Pneumocystis Jirovecii
23%
Prevalence
8%
Primary Prevention
7%
Pseudomonas aeruginosa
46%
Public Health
5%
Severe Acute Respiratory Syndrome
5%
Stem Cell Transplant
23%
Transplantation
100%
Virus Infection
23%
Virus RNA
23%
Virus Shedding
23%